David A. Alagpulinsa, PhD (@Alagsdave) header
David A. Alagpulinsa, PhD (@Alagsdave) profile picture

Assistant Professor @YaleMed⏐Human genetics, hematopoiesis & pleiotropy⏐Diabetes, cardiometabolic & neuroimmune disease⏐PI, Alagpulinsa Lab⏐Nature & Freedom⏐

New England, USA
Joined December 2012
Photo by David A. Alagpulinsa, PhD (@Alagsdave)Photo by David A. Alagpulinsa, PhD (@Alagsdave)Photo by David A. Alagpulinsa, PhD (@Alagsdave)Photo by David A. Alagpulinsa, PhD (@Alagsdave)Photo by David A. Alagpulinsa, PhD (@Alagsdave)Photo by David A. Alagpulinsa, PhD (@Alagsdave)Photo by David A. Alagpulinsa, PhD (@Alagsdave)Photo by David A. Alagpulinsa, PhD (@Alagsdave)Photo by David A. Alagpulinsa, PhD (@Alagsdave)Photo by David A. Alagpulinsa, PhD (@Alagsdave)
We are delighted to share our new work as a preprint on medRxiv, examining hematopoietic aging in type 1 diabetes (T1D). Analyzing data from >416,000 UK Biobank participants, we show that T1D is associated with accelerated hematopoietic aging, including earlier clonal hematopoiesis (CHIP) and disease-accelerated telomere attrition. Interestingly, telomere attrition—but not CHIP—was associated with myocardial infarction risk in T1D. By integrating epidemiology, human genetics, Mendelian randomization, and single-cell regulatory genomics, our work identifies telomere biology as a potential contributor to excess cardiovascular risk in T1D. This work was led by the incredibly talented Ziang Xu, who will join the University of Pennsylvania this summer for a PhD in Genomics & Computational Biology. Congratulations as well to co-author Sourav Roy, who will also join the Duke University MD/PhD this summer. We are very proud of them and excited to see them take this next step in their scientific journeys. Accelerated hematopoietic aging in type 1 diabetes links telomere attrition to myocardial infarction medrxiv.org/content/10.64898…
1
5
1,254
David A. Alagpulinsa, PhD retweeted
Our GWAS of educational attainment in 448,558 East Asians is out in Vita: 33 loci (11 ancestry-specific), 28 high-confidence genes, and the brain cell types behind them. Summary statistics freely available. @Vita_Journal @Rainee_rl @Westlake_Uni
A team led by Prof. Jian Yang at Westlake University, together with international collaborators, has published in @Vita_Journal the largest GWAS of educational attainment in East Asians to date, analyzing 448,558 individuals. The study reveals shared and ancestry-specific genetic associations, prioritizes candidate genes, and maps relevant brain cell types and their spatial distributions. #WestlakeUniversity #gwas #vita
2
19
74
2,232
David A. Alagpulinsa, PhD retweeted
A new study suggests that only between a quarter and a third of people diagnosed with #obesity on BMI alone are actually living with obesity-related illness. Researchers tested the clinical vs preclinical obesity framework proposed by the Lancet Commission in 2025, using health records of about 850,000 adults in China, the UK, the US and Spain. The criteria add a waist-based measure of body fat to #BMI and check for 18 obesity-related dysfunctions, such as cardiovascular disease, sleep apnoea and joint pain. On average, 27% of people with obesity had clinical obesity, around 8.5% of all adults. Clinical obesity was associated with a 69% higher risk of death from any cause. Depending on the cohort, 77–91% of people with preclinical obesity did not progress to clinical obesity within 10 years. The approach could help target care to those who need it most. More evidence is needed to show it improves #health outcomes and is practical in routine primary care. doi.org/10.1038/s41586-026-1…
4
15
1
25
2,356
David A. Alagpulinsa, PhD retweeted
New content online: Screening for early-stage type 1 diabetes mellitus dlvr.​it/TWHvnD
2
8
18
1,952
David A. Alagpulinsa, PhD retweeted
The recording of "Dissecting Noncoding Regulatory Elements to Understand the Logic of Gene Regulation” by @heejin_roh is now available: youtu.be/h3aD2N6Zop8. This talk is part of @broadinstitute's MPG Primer series. For more info, check out broad.io/MPGPrimer
11
46
3,243
David A. Alagpulinsa, PhD retweeted
🧬 Scientists May Have Found a Way to RESET Autoimmune Diseases Imagine treating lupus, MS, or type 1 diabetes not with lifelong medicine… but by rebooting the immune system itself. Scientists are now using genetically engineered immune cells to hunt down the exact cells causing autoimmune disease. In early trials, some patients experienced complete remission — something once thought impossible. Even more surprising? Many dangerous side effects seen in cancer treatments were missing. If these trials continue to succeed, this breakthrough could change millions of lives forever. Source: Mackensen, A., et al. Nature Medicine. “Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus.”
21
116
8
555
14,990
Genetic variation influences glycemic response to glucose-lowering medications, with SLC2A2 emerging as a genetic factor that modulates sulfonylurea response. Read here ➡️ doi.org/10.2337/dc26-1633 @AmDiabetesAssn @ADA_DiabetesPro @ADA_Pubs
2
1
8
699
David A. Alagpulinsa, PhD retweeted
A special issue of @ScienceMagazine on “GLP-1 and Beyond” is out this week. We contributed a Review on obesity pharmacotherapies and cognition, exploring their potential effects on brain health and the many questions that remain. science.org/doi/10.1126/scie…
3
15
99
15,954
David A. Alagpulinsa, PhD retweeted
A study of 1 million diverse genomes identified mutations in FNIP1 linked to more muscle, less belly fat & lower blood sugar. Carriers had a 60% reduced risk of cardiometabolic disease, pointing to a possible drug target for diabetes + heart disease nature.com/articles/d41586-0…
3
3
332
David A. Alagpulinsa, PhD retweeted
Online—Clinical and metabolic #subtypes of recent-onset adult type 1 #diabetes: a prospective cohort study thelancet.com/journals/landi… #T1D #OpenAccess
2
11
31
1,988
David A. Alagpulinsa, PhD retweeted
🚨 BIPOLAR GENETICS SOLVED? The largest sequencing study of bipolar disorder just identified 13 definitive risk genes. By analyzing ultra-rare coding variants across 232,536 individuals globally, BipEx 2.0 uncovers large-effect mutations that disrupt… Surprise surprise: neuronal synapses Sound familiar? Schizophrenia genetics converged on the same pathways in SCHEMA 3. It’s no wonder antipsychotics work for both disorders🧵
9
55
5
279
18,761
Type 1 diabetes was associated with higher risk of mortality, particularly among females. This association was attenuated among individuals diagnosed in more recent years. Read here ➡️ doi.org/10.2337/dc26-1472 @AmDiabetesAssn @ADA_DiabetesPro @ADA_Pubs
5
1
13
859
David A. Alagpulinsa, PhD retweeted
Peripheral neuroimmune dialogues underlying pain states dlvr.​it/TW92nn
23
2
73
8,144